
Colen Lab
17 posts

Colen Lab
@colen_lab
The Colen Lab at UPMC Hillman Cancer Center. #Radiomics #Radiogenomics #ImagingCore @UPMCnews @UPMCHillmanCC @PittRadiology
Pittsburgh, PA Katılım Ekim 2019
49 Takip Edilen46 Takipçiler
Colen Lab retweetledi

Hot off the press! Our group's new paper "Evolving Role and Translation of Radiomics and Radiogenomics in Adult and Pediatric Neuro-Oncology" at @TheAJNR @PittRadiology #Radiomics #AI #neurooncology
Congrats team! @rrcolen @colen_lab
ajnr.org/content/early/…
English

Congratulations team! Great work! @drmuratak @PittRadiology @UPMCHillmanCC @ANaingMD @ChristianRolfo
Murat Ak@rad_murat
I am happy to share our group`s new #radiomics paper "Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers" @jitcancer jitc.bmj.com/content/9/4/e0… @rrcolen @ANaingMD @ChristianRolfo @colen_lab @PittRadiology #ArtificialIntelligence
English
Colen Lab retweetledi

Opening for 4 post-doctoral fellows to work in our Imaging Core @colen_lab at Hillman Cancer Center @UPMC. #fmg #radiology #postdoc @imaging The candidate must have radiology training and will perform tumor measurements such as RECIST, irRC, etc. please email colenrr@upmc.edu
Pittsburgh, PA 🇺🇸 English
Colen Lab retweetledi
Colen Lab retweetledi

Phase II Study of Pembrolizumab in Advanced Rare Cancers Shows Promise cancernetwork.com/article/phase-… @ANaingMD @LabNaing @MDAndersonNews
English
Colen Lab retweetledi

While treatment of rare cancers remains a significant challenge, this phase 2 study with Pembrolizumab sheds some light. We thank the patients, caregivers, investigators @MDAndersonNews and collaborators. Thank you @jitcancer for publishing our work.
jitc.bmj.com/content/8/1/e0…

English
Colen Lab retweetledi

ICYMI: A new MD Anderson-led study could lead to a new treatment option for patients with #rarecancers: bit.ly/3b8uwk5 @ANaingMD #endcancer
English
Colen Lab retweetledi
Colen Lab retweetledi

A Phase II clinical trial led by our @ANaingMD found #immunotherapy may be effective in some #rarecancers, including squamous cell carcinoma of the skin, carcinoma of unknown primary, adrenocortical carcinoma and paraganglioma-pheochromocytoma: bit.ly/3b8uwk5 #endcancer
English
Colen Lab retweetledi

Are #Cancer Patients at Higher Risk of Death with #COVID19? Our late-breaking article @JIPOEditors Free download jipoonline.org/preprintarticl…
@Dr_R_Kurzrock @jacobadashek Roy Chemaly @BCMFromtheLabs @TCHResearchNews @MDAndersonNews @MoffittNews @UCSDHealth #immunodeficiency
English

Presenting our radiomic models that predict pembrolizumab response on patients with advanced rare cancer @ASCO IO Symposium. Thank you to my amazing mentor @rrcolen for all her advice. @PittRadiology @UPMC @UPMCHillmanCC @ANaingMD #ImmunoOnc20 #radiomic



English

Awesome and fruitful collaboration @colen_lab @ANaingMD @DavidHongMD @VivekSubbiah on #radiomics to predict response to #pembrolizumab in patients with advance #cancer . @UPMCnews @UPMCnews @UPMCHillmanCC @MDAndersonNews @pascalzinn
English

I am honored to receive this Patient’s Choice Award and to continue to provide excellent care for our patients here at Baylor!
NiekroFoundation@joeniekro
The Joe Niekro Foundation is pleased to announce our 2020 Houston Knuckle Ball, Patient's Choice Award Recipients: DR. ORLANDO DIAZ DR. GARY SPIEGEL DR. JAN-KARL BURKHARDT Thank you doctors for your dedication to your patients!
English
Colen Lab retweetledi

New rotating student on service....drawing some complex brain stem nuclei map...perhaps....@PittNeurosurg @rrcolen

English